Maltose: Stabilize Intravenous IG Infusions
Source: Pfanstiehl, Inc.
Maltose is a disaccharide consisting of two glucose molecules with an α-1,4 glucosidic bond. Upon injection, it is only requires a minimal amount of insulin, having little impact influence on blood-sugar levels. Hence, it is commonly used to stabilize intravenous IG infusions, among other protein-based formulations.
Pfanstiehl Brand, High Purity Low Endotoxin (HPLE) Maltose is a high quality, pharmaceutical grade maltose that can be used in bioprocessing and parenteral applications. In addition to use in nutritional intravenous fluids in certain countries, it can be also used as an excipient for protein stabilization.
This website uses cookies to ensure you get the best experience on our website. Learn more